NCT06822374View on ClinicalTrials.gov

Hypertonic Saline in Posterior Spinal Fusion

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Scoliosis IdiopathicScoliosis;Congenital
Interventions
DRUG

Normosol-R

Standard of care isotonic fluid.

DRUG

buffered 2% hypertonic saline

"A solution containing 2% sodium chloride (NaCl) that is buffered by the addition of another salt like sodium acetate."

Trial Locations (1)

43205

Nationwide Children's, Columbus

All Listed Sponsors
lead

Joseph D. Tobias

OTHER